These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6411893)

  • 41. Transdermal absorption of nitroglycerin from microseal drug delivery (MDD) system.
    Karim A
    Angiology; 1983 Jan; 34(1):11-22. PubMed ID: 6401951
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic-hemodynamic studies of transdermal nitroglycerin in congestive heart failure.
    Armstrong PW
    J Am Coll Cardiol; 1987 Feb; 9(2):420-5. PubMed ID: 3100600
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacokinetic relationships between cinromide and its metabolites in the rhesus monkey I: 3-Bromocinnamamide, an active metabolite.
    Lane EA; Levy RH
    J Pharm Sci; 1983 May; 72(5):493-6. PubMed ID: 6864493
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The metabolism of zomepirac sodium. I. Disposition in laboratory animals and man.
    Grindel JM; O'Neill PJ; Yorgey KA; Schwartz MH; McKown LA; Migdalof BH; Wu WN
    Drug Metab Dispos; 1980; 8(5):343-8. PubMed ID: 6107233
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma levels of nitroglycerin generated by three nitroglycerin patch preparations, Nitradisc, Transiderm-Nitro and Nitro-Dur and one ointment formulation, Nitrobid.
    McAllister A; Mosberg H; Settlage JA; Steiner JA
    Br J Clin Pharmacol; 1986 Apr; 21(4):365-9. PubMed ID: 3085698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of triclopyr (3,5,6-trichloro-2-pyridinyloxyacetic acid) in the beagle dog and rhesus monkey: perspective on the reduced capacity of dogs to excrete this organic acid relative to the rat, monkey, and human.
    Timchalk C; Nolan RJ
    Toxicol Appl Pharmacol; 1997 Jun; 144(2):268-78. PubMed ID: 9194410
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The percutaneous absorption of propranolol and prediction of the plasma concentration.
    Ogiso T; Ito Y; Iwaki M; Shintani A
    J Pharmacobiodyn; 1988 May; 11(5):349-55. PubMed ID: 3171877
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of (-)-beta-D-dioxolane guanine and prodrug (-)-beta-D-2,6-diaminopurine dioxolane in rats and monkeys.
    Chen H; Schinazi RF; Rajagopalan P; Gao Z; Chu CK; McClure HM; Boudinot FD
    AIDS Res Hum Retroviruses; 1999 Dec; 15(18):1625-30. PubMed ID: 10606085
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Orally active inhibitors of human leukocyte elastase. II. Disposition of L-694,458 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Luffer-Atlas D; Karanam BV; McGowan E; Cioffe C; Doss G; Chiu SH
    Drug Metab Dispos; 1997 Aug; 25(8):932-9. PubMed ID: 9280401
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Plasma nitroglycerin concentrations and hemodynamic effects of sublingual, ointment, and controlled-release forms of nitroglycerin.
    Curry SH; Kwon HR; Perrin JH; Culp JR; Pepine CJ; Yu WC; Stevens JL
    Clin Pharmacol Ther; 1984 Dec; 36(6):765-72. PubMed ID: 6437723
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of the antiviral agent beta-L-3'-fluoro-2',3'-didehydro-2',3'-dideoxycytidine in rhesus monkeys.
    Asif G; Hurwitz SJ; Gumina G; Chu CK; McClure HM; Schinazi RF
    Antimicrob Agents Chemother; 2005 Feb; 49(2):560-4. PubMed ID: 15673733
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous absorption of testosterone in the newborn rhesus monkey: comparison to the adult.
    Wester RC; Noonan PK; Cole MP; Maibach HI
    Pediatr Res; 1977 Jun; 11(6):737-9. PubMed ID: 405649
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of rolipram in the rhesus and cynomolgus monkeys, the rat and the rabbit. Studies on species differences.
    Krause W; Kühne G
    Xenobiotica; 1988 May; 18(5):561-71. PubMed ID: 3400274
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.
    Noonan PK; Williams RL; Benet LZ
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):143-57. PubMed ID: 3932639
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Terminal half-lives in plasma and bioavailability of norethisterone, levonorgestrel, cyproterone acetate and gestodene in rats, beagles and rhesus monkeys.
    Düsterberg B; Hümpel M; Speck U
    Contraception; 1981 Dec; 24(6):673-83. PubMed ID: 6459908
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Half-lives in plasma and bioavailability of ethinylestradiol in laboratory animals.
    Düsterberg B; Kühne G; Täuber U
    Arzneimittelforschung; 1986 Aug; 36(8):1187-90. PubMed ID: 3778555
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Disposition of gabapentin (neurontin) in mice, rats, dogs, and monkeys.
    Radulovic LL; Türck D; von Hodenberg A; Vollmer KO; McNally WP; DeHart PD; Hanson BJ; Bockbrader HN; Chang T
    Drug Metab Dispos; 1995 Apr; 23(4):441-8. PubMed ID: 7600909
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Percutaneous absorption of valproic acid and its plasma concentration after application of ointment.
    Ogiso T; Ito Y; Iwaki M; Yamamoto Y; Yamahata T
    J Pharmacobiodyn; 1987 Oct; 10(10):537-42. PubMed ID: 3126287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma concentration of cutaneously applied trinitroglycerin.
    Magometschnigg D; Horwatitsch H; Pichler M
    Int J Clin Pharmacol Ther Toxicol; 1983 Apr; 21(4):178-82. PubMed ID: 6408014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prediction of plasma concentration profile during single and repeated skin applications of indomethacin and its calcium salt ointments.
    Ogiso T; Ito Y; Iwaki M; Atago H
    J Pharmacobiodyn; 1987 Aug; 10(8):384-9. PubMed ID: 3694433
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.